1 1923 137 ROLE OF YOGA AS AN ADJUNCTIVE THERAPY IN PATIENTS WITH NEUROCARDIOGENIC SYNCOPE: A PILOT STUDY. BACKGROUND: NEUROCARDIOGENIC SYNCOPE (NCS) IS A COMMON CLINICAL CONDITION CHARACTERIZED BY ABRUPT CARDIOVASCULAR AUTONOMIC CHANGES RESULTING IN SYNCOPE. THIS IS A RECURRING CONDITION WITH MIXED RESULTS FROM CURRENT STRATEGIES OF TREATMENT. METHODS: SUBJECTS WITH A DIAGNOSIS OF NCS WERE SCREENED AND ENROLLED. ALL THE PARTICIPANTS WERE GIVEN A DVD CONTAINING YOGA VIDEOS AND WERE INSTRUCTED TO PRACTICE YOGA THERAPY FOR 60 MIN, THREE TIMES A WEEK FOR 3 CONSECUTIVE MONTHS. SYNCOPE FUNCTIONAL STATUS QUESTIONNAIRE SCORE (SFSQS) WAS ADMINISTERED AT THE BEGINNING AND THE END OF THE STUDY. THE SUBJECTS WERE FOLLOWED FOR 3 MONTHS AND UNDERWENT REPEAT TILT TABLE TESTING AT THE END OF THE STUDY. RESULTS: OF THE 60 PATIENTS SCREENED, 44 SUBJECTS WERE ENROLLED, 21 IN THE INTERVENTION GROUP AND 23 IN THE CONTROL GROUP. MOST OF THE PARTICIPANTS WERE FEMALES, AND THE MEAN AGE WAS 21 +/- 3 YEARS. IN THE INTERVENTION GROUP, WHO FINISHED THE YOGA REGIMEN, THERE WAS A STATISTICALLY SIGNIFICANT IMPROVEMENT FROM CONTROL PHASE TO THE INTERVENTION PHASE, IN NUMBER OF EPISODES OF SYNCOPE (4 +/- 1 VS 1.3 +/- 0.7, P < 0.001) AND PRESYNCOPE (4.7 +/- 1.5 VS 1.5 +/- 0.5, P < 0.001). THE MEAN SFSQS ALSO DECREASED FROM 67 +/- 7.8 TO 29.8 +/- 4.6 (P < 0.001). ALL SUBJECTS HAD POSITIVE HEAD UP TILT TABLE (HUTT) STUDY AT THE TIME OF ENROLLMENT COMPARED TO ONLY SIX PATIENTS AT THE COMPLETION OF INTERVENTION PHASE (10/100 VS 6/28 %, P < 0.0001). CONCLUSION: YOGA THERAPY CAN POTENTIALLY IMPROVE THE SYMPTOMS OF PRESYNCOPE AND SYNCOPE IN YOUNG FEMALE PATIENTS WITH NCS. 2015 2 2653 48 YOGA IMPROVES OCCUPATIONAL PERFORMANCE, DEPRESSION, AND DAILY ACTIVITIES FOR PEOPLE WITH CHRONIC PAIN. BACKGROUND: CHRONIC PAIN IS A COMPLEX ACCUMULATION OF PHYSICAL, PSYCHOLOGICAL, AND SOCIAL CONDITIONS, THUS INTERVENTIONS THAT ADDRESS PAIN AND PROMOTE OCCUPATIONAL PERFORMANCE ARE NEEDED. A HOLISTIC INTERVENTION, WITH MIND AND BODY COMPONENTS, IS LIKELY NECESSARY TO BEST TREAT THE COMPLEXITIES OF CHRONIC PAIN. THUS, WE DEVELOPED AND TESTED A YOGA INTERVENTION FOR PEOPLE WITH CHRONIC PAIN. OBJECTIVES: IN A RANDOMIZED CONTROL TRIAL (RCT), PARTICIPANTS WITH CHRONIC PAIN WERE RANDOMIZED TO A YOGA INTERVENTION OR USUAL CARE GROUP. BETWEEN AND WITHIN GROUP DIFFERENCES FOR PRE-AND POST-OUTCOME MEASURE SCORES WERE ASSESSED FOR: OCCUPATIONAL PERFORMANCE, COMPLETION OF ACTIVITIES, AND DEPRESSION. METHODS: PILOT RCT WITH PARTICIPANT ALLOCATION TO 8 WEEKS OF YOGA OR USUAL CARE. BOTH GROUPS RECEIVED ONGOING MONTHLY SELF-MANAGEMENT PROGRAMMING. DATA WERE COLLECTED BEFORE AND AFTER THE 8-WEEK INTERVENTION. PARTICIPANTS WERE RANDOMIZED TO YOGA OR USUAL CARE AFTER BASELINE ASSESSMENTS. DEMOGRAPHICS WERE COLLECTED AND MEASURES INCLUDED: CANADIAN OCCUPATIONAL PERFORMANCE MEASURE (COPM) TO ASSESS OCCUPATIONAL PERFORMANCE; THE 15-ITEM FRENCHAY ACTIVITIES INDEX (FAI)(ACTIVITIES); AND THE 9-ITEM PATIENT HEALTH QUESTIONNAIRE (PHQ-9) FOR DEPRESSION. INDEPENDENT T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN GROUPS. PAIRED T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN PRE- AND POST 8-WEEK INTERVENTION FOR BOTH THE YOGA AND THE USUAL CARE GROUPS. PERCENT CHANGE SCORES AND EFFECT SIZES WERE CALCULATED. RESULTS: 83 PEOPLE WERE RECRUITED FOR THE STUDY AND COMPLETED BASELINE ASSESSMENTS; 44 INDIVIDUALS WERE RANDOMIZED TO YOGA AND 39 TO THE CONTROL GROUP. THE AVERAGE AGE OF ALL PARTICIPANTS WAS 51.4+/-10.5 YEARS, 68% WERE FEMALE; AND 60% HAD AT LEAST SOME COLLEGE EDUCATION. THERE WERE NO SIGNIFICANT DIFFERENCES IN DEMOGRAPHICS OR OUTCOME MEASURES BETWEEN GROUPS AT BASELINE OR 8 WEEKS; HOWEVER, THE STUDY WAS NOT POWERED TO SEE SUCH DIFFERENCES. INDIVIDUALS RANDOMIZED TO THE CONTROL GROUP DID NOT SIGNIFICANTLY IMPROVE IN ANY OUTCOME MEASURE OVER THE 8 WEEKS. THERE WERE SIGNIFICANT IMPROVEMENTS IN COPM PERFORMANCE AND COPM SATISFACTION SCORES FOR INDIVIDUALS RANDOMIZED TO THE YOGA GROUP; BOTH SCORES SIGNIFICANTLY IMPROVED. COPM PERFORMANCE IMPROVED BY 27% WITH A MODERATE TO LARGE EFFECT SIZE (3.66+/-1.85 VS 4.66+/-1.93, P < 0.001, D = 0.76). COPM SATISFACTION SIGNIFICANTLY IMPROVED BY 78% (2.14+/-2.31 VS. 3.80+/-2.50, P < 0.001) AND HAD A LARGE EFFECTS SIZE (D = 1.02). FAI SCORES IMPROVED, INDICATING INCREASED ACTIVITY OR ENGAGEMENT IN DAILY OCCUPATION DURING THE 8-WEEK INTERVENTION. SCORES INCREASED BY 5% (38.13+/-8.48 VS. 39.90+/-8.57, P = 0.024) WITH A SMALL EFFECT SIZE (D = 0.37). DEPRESSION SIGNIFICANTLY DECREASED FROM 13.21+/-5.60 TO 11.41+/-5.82, P = 0.041, WITH A SMALL EFFECT SIZE. CONCLUSION: DATA FROM THIS PILOT RCT INDICATE YOGA MAY BE AN EFFECTIVE THERAPEUTIC INTERVENTION WITH PEOPLE IN CHRONIC PAIN TO IMPROVE OCCUPATIONAL PERFORMANCE, INCREASE ENGAGEMENT IN ACTIVITIES, AND DECREASE DEPRESSION. OCCUPATIONAL THERAPY PRACTITIONERS MAY CONSIDER ADDING YOGA AS A TREATMENT INTERVENTION TO ADDRESS THE NEEDS OF PEOPLE WITH PAIN. 2019 3 459 42 CHANGES IN PAIN INTENSITY AND HEALTH RELATED QUALITY OF LIFE WITH IYENGAR YOGA IN NONSPECIFIC CHRONIC LOW BACK PAIN: A RANDOMIZED CONTROLLED STUDY. BACKGROUND: NONSPECIFIC CHRONIC LOW BACK (NCLBP) PAIN IS PREVALENT AMONG ADULT POPULATION AND OFTEN LEADS TO FUNCTIONAL LIMITATIONS, PSYCHOLOGICAL SYMPTOMS, LOWER QUALITY OF LIFE (QOL), AND HIGHER HEALTHCARE COSTS. THE PURPOSE OF THIS STUDY WAS TO DETERMINE THE EFFICACY OF IYENGAR YOGA THERAPY ON PAIN INTENSITY AND HEALTH RELATED QUALITY OF LIFE (HRQOL) WITH NCLBP. AIM OF THE STUDY: TO COMPARE THE EFFECT OF IYENGAR YOGA THERAPY AND CONVENTIONAL EXERCISE THERAPY ON PAIN INTENSITY AND HRQOL IN NONSPECIFIC CHRONIC LOW BACK PAIN. MATERIALS AND METHODS: EXPERIMENTAL STUDY WITH RANDOM SAMPLING TECHNIQUE. SUBJECTS/INTERVENTION: SIXTY SUBJECTS WHO FULFILLED THE SELECTION CRITERIA WERE RANDOMLY ASSIGNED TO IYENGAR YOGA (YOGA GROUP, N = 30) AND CONTROL GROUP (EXERCISE GROUP, N = 30). PARTICIPANTS COMPLETED LOW BACK PAIN EVALUATION FORM AND HRQOL-4 QUESTIONNAIRE BEFORE THEIR INTERVENTION AND AGAIN 4 WEEKS AND 6 MONTH LATER. YOGA GROUP UNDERWENT 29 YOGIC POSTURES TRAINING AND EXERCISE GROUP HAD UNDERGONE GENERAL EXERCISE PROGRAM FOR 4 WEEKS. STATISTICS: REPEATED MEASURES ANALYSIS OF VARIANCE (ANOVA) WAS USED TO ANALYZE GROUP DIFFERENCES OVER TIME, WHILE CONTROLLING FOR BASELINE DIFFERENCES. RESULTS: PATIENTS IN BOTH GROUPS EXPERIENCED SIGNIFICANT REDUCTION IN PAIN AND IMPROVEMENT IN HRQOL. IN VISUAL ANALOGUE SCALE (VAS) YOGA GROUP SHOWED REDUCTION OF 72.81% (P = 0.001) AS COMPARED TO EXERCISE GROUP 42.50% (P = 0.001). IN HRQOL, YOGA GROUP SHOWED REDUCTION OF 86.99% (P = 0.001) AS COMPARED TO EXERCISE GROUP 67.66% (P = 0.001). CONCLUSION: THESE RESULTS SUGGEST THAT IYENGAR YOGA PROVIDES BETTER IMPROVEMENT IN PAIN REDUCTION AND IMPROVEMENT IN HRQOL IN NONSPECIFIC CHRONIC BACK PAIN THAN GENERAL EXERCISE. 2014 4 2103 31 THE EFFECT OF YOGA ON FUNCTIONAL RECOVERY LEVEL IN SCHIZOPHRENIC PATIENTS. PURPOSE: THE OBJECTIVE OF THIS STUDY IS TO DETERMINE THE EFFECT OF YOGA ON FUNCTIONAL RECOVERY LEVEL IN SCHIZOPHRENIC PATIENTS. MATERIALS AND METHODS: THE STUDY WAS CONDUCTED IN QUASI-EXPERIMENTAL DESIGN WITH PRETEST-POSTTEST CONTROL GROUP. THE POPULATION OF THE STUDY CONSISTED OF SCHIZOPHRENIC PATIENTS WITH REGISTERED IN MALATYA AND ELAZIG COMMUNITY MENTAL HEALTH CENTERS AND REGULARLY GOING TO THESE CENTERS. THE SAMPLE GROUP OF THE STUDY CONSISTED OF TOTALLY 100 PATIENTS INCLUDING 50 PATIENTS IN THE EXPERIMENTAL GROUP AND 50 PATIENTS IN THE CONTROL GROUP WHO WERE SPECIFIED THROUGH POWER ANALYSIS AND CHOSEN BY USING RANDOM SAMPLING METHOD FROM THIS POPULATION. THE DATA WERE COLLECTED BETWEEN APRIL 2015 AND AUGUST 2015. 'PATIENT DESCRIPTION FORM' AND 'FROGS' WERE USED TO COLLECT THE DATA. YOGA WAS APPLIED TO PATIENTS IN THE EXPERIMENTAL GROUP. ANY INTERVENTION WAS NOT MADE TO PATIENTS IN THE CONTROL GROUP. PERCENTAGE DISTRIBUTION, ARITHMETIC MEAN, STANDARD DEVIATION, CHI-SQUARE, INDEPENDENT SAMPLES T TEST, AND PAIRED T TEST WERE USED TO ASSESS THE DATA. RESULTS: PATIENTS IN THE CONTROL AND EXPERIMENTAL GROUP PRETEST SUBSCALE AND THE TOTAL MEANS SCORES OF FROGS WAS FOUND TO BE LOW. IN THE POSTTEST SUBSCALE AND TOTAL MEANS SCORES OF FROGS IN THE EXPERIMENTAL GROUP WERE HIGHER THAN IN THE CONTROL GROUP AND THE DIFFERENCES BETWEEN THEM WERE FOUND TO BE STATISTICALLY SIGNIFICANT (P<0.05). IN THE EXPERIMENTAL GROUP PRETEST AND POSTTEST SUBSCALE AND TOTAL MEANS SCORES OF FR0GS WAS DETERMINED TO BE STATISTICALLY SIGNIFICANT (P<0.05). CONCLUSION: YOGA THAT APPLIED TO SCHIZOPHRENIC PATIENTS IT WAS DETERMINED TO INCREASED THE LEVEL OF FUNCTIONAL RECOVERY. IT CAN BE SUGGESTED THAT YOGA SHOULD BE USED AS AN COMPLEMENTARY METHOD IN NURSING PRACTISE IN ORDER TO INCREASE THE EFFECTIVENESS OF THE TREATMENT. 2016 5 1818 40 PROSPECTIVE RANDOMIZED TRIAL OF STANDARD ANTIEMETIC THERAPY WITH YOGA VERSUS STANDARD ANTIEMETIC THERAPY ALONE FOR HIGHLY EMETOGENIC CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN SOUTH ASIAN POPULATION. AIM/BACKGROUND: CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IS ONE OF THE MOST DISTRESSING SIDE EFFECTS OF HIGHLY EMETOGENIC CHEMOTHERAPY REGIMENS. THERE HAVE BEEN CONTINUOUS EFFORTS IN THE DIRECTION TO CONTROL CINV BY MANY INVESTIGATORS. MATERIALS AND METHODS: RANDOMLY SELECTED PATIENTS WERE THOSE RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY REGIMEN GROUPED INTO YOGA AND STANDARD ANTIEMETIC THERAPY (N = 50) JUST BEFORE RECEIVING CHEMOTHERAPY AND CONTINUED FOR THE FOLLOWING DAYS AND OTHER GROUP (N = 50) RECEIVED ONLY THE STANDARD ANTIEMETIC AGENT. BOTH THE GROUPS WERE ASSESSED, FOLLOWED FOR ACUTE AND DELAYED ONSET OF CHEMOTHERAPY-INDUCED AND ANTICIPATORY NAUSEA AND VOMITING USING RADIATION THERAPY ONCOLOGY GROUP GRADING FOR THE SAME. WE ALSO ASSESSED THE QUALITY OF LIFE OF THE PATIENT USING THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY-GENERAL QUESTIONNAIRE. RESULTS: THE MEDIAN AGE GROUP OF THE PATIENTS WAS 51 YEARS WITH MALE:FEMALE RATIO 2:1, THE EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) PERFORMANCE STATUS WAS 0/1 IN 38% OF THE SELECTED POPULATION, WHILE ECOG 2 IN 62% OF THE PATIENTS. IN YOGA ARM, INSIGNIFICANT REDUCTION IN CHEMOTHERAPY-INDUCED NAUSEA (90% VS. 78%, P = 0.35) AND BUT SIGNIFICANT REDUCTION IN VOMITING (42% VS. 22%, P =0.01) WAS OBSERVED AS COMPARED TO THE STANDARD ANTIEMETICS ONLY ARM. THERE WAS A SIGNIFICANT REDUCTION IN GRADE 2 AND 3 NAUSEA (84% VS. 38% P < 0.01) AND VOMITING (14% VS. 0% P < 0.01). QUALITY OF LIFE IS ALSO SIGNIFICANTLY IMPROVED IN THE YOGA ARM, ESPECIALLY IN THE ECOG 2 PERFORMANCE STATUS. CONCLUSIONS: THIS STUDY CONCLUDES THAT YOGA ALONG WITH STANDARD ANTIEMETIC MEDICATION SHOULD BE A PART OF THE MANAGEMENT PLAN FOR THE CANCER PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY. 2019 6 2464 40 YOGA AS A THERAPEUTIC INTERVENTION IN THE MANAGEMENT OF DYSFUNCTIONAL UTERINE BLEEDING: A CONTROLLED PILOT STUDY. BACKGROUND: DYSFUNCTIONAL UTERINE BLEEDING (DUB) IS ONE OF THE MOST COMMON GYNECOLOGICAL DISORDERS ENCOUNTERED IN WOMEN DURING THE REPRODUCTIVE AGE. YOGA THERAPY HAS SHOWN PROMISING BENEFITS IN SEVERAL GYNECOLOGICAL DISORDERS. METHODS: THIRTY WOMEN BETWEEN THE AGES OF 20 AND 40 YEARS WITH PRIMARY DUB WERE RANDOMLY ASSIGNED TO A YOGA (N = 15) AND A WAITLIST CONTROL GROUP (N = 15). PARTICIPANTS IN THE YOGA GROUP RECEIVED A 3-MONTH YOGA MODULE AND WERE ASSESSED FOR HEMOGLOBIN VALUES, ENDOMETRIAL THICKNESS (ET), PICTORIAL BLOOD LOSS ASSESSMENT CHART (PBAC), STATE-TRAIT ANXIETY INVENTORY, PERCEIVED STRESS SCALE, AND PITTSBURGH SLEEP QUALITY INDEX (PSQI) BEFORE AND AFTER A 3-MONTH FOLLOW-UP PERIOD. RESULTS: AT THE END OF 3 MONTHS OF INTERVENTION, THE YOGA GROUP, UNLIKE THE CONTROL GROUP, REPORTED A SIGNIFICANT REDUCTION IN THE ANXIETY SCORES (P < 0.05) AND PERCEIVED STRESS (P < 0.05). THE PSQI SCORES INDICATED A REDUCTION IN SLEEP DISTURBANCES (P < 0.001) AND THE NEED FOR SLEEP MEDICATIONS (P < 0.01) AND HIGHER GLOBAL SCORES (P < 0.001). HOWEVER, THERE WERE NO CHANGES IN PBAC AND ET IN BOTH THE GROUPS. CONCLUSION: THE RESULTS INDICATE THAT YOGA THERAPY POSITIVELY IMPACTS THE OUTCOME OF DUB BY REDUCING THE PERCEIVED STRESS AND STATE ANXIETY AND IMPROVING THE QUALITY OF SLEEP. THIS WARRANTS LARGER CLINICAL TRIALS TO VALIDATE THE FINDINGS OF THIS PILOT STUDY. 2018 7 1081 35 EFFECTS OF YOGA ON SEXUAL FUNCTION IN WOMEN WITH METABOLIC SYNDROME: A RANDOMIZED CONTROLLED TRIAL. INTRODUCTION: FEMALE SEXUAL DYSFUNCTION IS AN IMPORTANT PUBLIC HEALTH ISSUE; IT HAS A HIGH GLOBAL PREVALENCE, BUT NO EFFECTIVE AND SAFE TREATMENT OPTIONS. THE PREVALENCE OF SEXUAL DYSFUNCTION IS HIGHER IN WOMEN WITH METABOLIC SYNDROME THAN IN THE GENERAL POPULATION. AIM: THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFICACY OF YOGA AS A TREATMENT FOR SEXUAL DYSFUNCTION IN WOMEN WITH METABOLIC SYNDROME. METHODS: IN THIS RANDOMIZED, CONTROLLED STUDY, 41 WOMEN WITH METABOLIC SYNDROME (AGE 30-60 YEARS) WERE ASSIGNED TO A 12-WEEK YOGA EXERCISE GROUP (N=20) OR A WAIT-LISTED CONTROL GROUP (N=21). MAIN OUTCOME MEASURES: PRIMARY END POINTS WERE CHANGES IN TOTAL AND INDIVIDUAL DOMAIN SCORES ON THE FEMALE SEXUAL FUNCTION INDEX. RESULTS: THE 12-WEEK YOGA INTERVENTION RESULTED IN SIGNIFICANT IMPROVEMENT IN AROUSAL (0.74+/-1.18 VS. 0.16+/-0.82, RESPECTIVELY; P=0.042) AND LUBRICATION (0.72+/-1.12 VS. 0.06+/-0.87, RESPECTIVELY; P=0.008) COMPARED WITH THE CONTROL GROUP. SYSTOLIC BLOOD PRESSURE SHOWED SIGNIFICANTLY GREATER IMPROVEMENT IN THE YOGA GROUP THAN IN THE CONTROL GROUP AT THE 12-WEEK FOLLOW UP (-3.5+/-13.7 VS. 2.0+/-14.7, RESPECTIVELY; P=0.040). CONCLUSION: THESE FINDINGS SUGGEST THAT YOGA MAY BE AN EFFECTIVE TREATMENT FOR SEXUAL DYSFUNCTION IN WOMEN WITH METABOLIC SYNDROME AS WELL AS FOR METABOLIC RISK FACTORS. 2013 8 2112 36 THE EFFECT OF YOGA ON STRESS, ANXIETY, AND DEPRESSION IN WOMEN. BACKGROUND: IN RECENT DECADES, SEVERAL MEDICAL AND SCIENTIFIC STUDIES ON YOGA PROVED IT TO BE VERY USEFUL IN THE TREATMENT OF SOME DISEASES. THIS STUDY WAS CONDUCTED TO INVESTIGATE THE EFFECTS OF YOGA ON STRESS, ANXIETY, AND DEPRESSION IN WOMEN LIVING IN ILAM, IRAN. METHODS: THIS STUDY IS A QUASI-EXPERIMENTAL STUDY WITH PRE-POST TEST. TO COLLECT DATA, THE QUESTIONNAIRE OF DASS-21 (DEPRESSION ANXIETY STRESS SCALE-21) WAS USED. FOR ELIGIBLE SAMPLES, HATHA YOGA EXERCISES AND TRAINING SESSIONS WERE HELD FOR 4 WEEKS (3 TIME/WEEKS; 60-70 MIN EACH) BY A SPECIALIST. DATA WERE ANALYZED USING SPSS VERSION 20. RESULTS: 52 WOMEN WITH A MEAN AGE OF 33.5 +/- 6.5 WERE INCLUDED FOR ANALYSIS. DEPRESSION, ANXIETY, AND STRESS DECREASED SIGNIFICANTLY IN WOMEN AFTER 12 SESSIONS OF REGULAR HATHA YOGA PRACTICE (P < 0.001). CONCLUSIONS: YOGA HAS AN EFFECTIVE ROLE IN REDUCING STRESS, ANXIETY, AND DEPRESSION. THUS, IT CAN BE USED AS COMPLEMENTARY MEDICINE. 2018 9 771 39 EFFECT OF YOGA AND AEROBICS EXERCISE ON SLEEP QUALITY IN WOMEN WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: THE AIM OF THIS STUDY WAS INVESTIGATING THE EFFECT OF 12 WEEKS OF YOGA AND AEROBIC EXERCISE (RUNNING ON A TREADMILL) ON THE SLEEP QUALITY IN WOMEN WITH TYPE 2 DIABETES. MATERIALS AND METHODS: 39 DIABETIC WOMEN WERE SELECTED FROM SEMNAN CITY WITH THE MEAN AGE OF 46.85+/-3.35 YEARS, WEIGHT OF 69.79+/-17.18 KG, HEIGHT OF 155.03+/-5.00, BMI OF 29.64+/-5.00 KG/M(2) WHO HAD A BACKGROUND OF DIABETES FOR 6.46+/-2.69 YEARS. THEY WERE THEN RANDOMLY DIVIDED INTO YOGA EXERCISE (N=15), AEROBIC EXERCISE (N=13), AND CONTROL GROUP (N=11). THE EXERCISE PROGRAM WAS PERFORMED FOR 12 WEEKS, THREE SESSIONS PER EACH WEEK. IN ORDER TO MEASURE THE SLEEP QUALITY, THE PITTSBURGH SLEEP QUALITY INDEX (PSQI) WAS USED. THE DATA WERE ANALYZED BY NON-PARAMETRIC WILCOXON AND KRUSKAL-WALLIS TEST AT SIGNIFICANCE LEVEL OF P<0.05. RESULTS: OVERALL SCORE OF SLEEP QUALITY IMPROVED AFTER SIX (P=0.001) AND 12 (P=0.001) WEEKS OF YOGA EXERCISE. ALSO, SIGNIFICANT EFFECT WAS OBSERVED AFTER 6 WEEKS OF AEROBIC EXERCISE (P=0.039). HOWEVER, THE POSITIVE EFFECT WAS DIMINISHED TO UNDER SIGNIFICANT LEVELS AFTER 12 WEEKS OF AEROBIC EXERCISE (P=0.154). KRUSKAL-WALLIS TEST SHOWED SIGNIFICANT DIFFERENCES BETWEEN YOGA AND AEROBIC GROUPS AFTER 12 WEEKS OF EXERCISE (P=0.002). NO SIGNIFICANT DIFFERENCES WERE OBSERVED IN CONTROL GROUPS IN ALL SITUATION. CONCLUSIONS: IT CAN BE CONCLUDED THAT YOGA EXERCISE IS MORE EFFECTIVE IN IMPROVING THE SLEEP QUALITY IN COMPARISON WITH THE SAME COURSE OF AEROBIC EXERCISE IN WOMEN SUFFERING FROM DIABETES TYPE 2. THUS, YOGA EXERCISE CAN BE SUGGESTED TO THESE PATIENTS. 2017 10 1380 36 IMPACT OF LONG TERM YOGA PRACTICE ON SLEEP QUALITY AND QUALITY OF LIFE IN THE ELDERLY. BACKGROUND: SLEEP DISTURBANCES AND DECLINE IN THE PHYSICAL FUNCTIONALITY ARE COMMON CONDITIONS ASSOCIATED WITH AGING. PHARMACOLOGICAL TREATMENT OF SLEEP DISTURBANCES CAN BE ASSOCIATED WITH VARIOUS ADVERSE EFFECTS. SHORT TERM TRIALS OF YOGA ON SLEEP HAVE SHOWN BENEFICIAL EFFECTS. OBJECTIVES: TO EVALUATE THE EFFECT OF LONG-TERM YOGA EXERCISES ON SLEEP QUALITY AND QUALITY OF LIFE (QOL) IN THE ELDERLY. MATERIALS AND METHODS: THIS WAS A CROSS-SECTIONAL STUDY IN WHICH DATA WERE COLLECTED FROM ELDERLY PEOPLE AGED 60 YEARS OR MORE LIVING IN NAGPUR CITY. WE EMPLOYED TWO TYPES OF SURVEY QUESTIONNAIRES: PITTSBURGH SLEEP QUALITY INDEX (PSQI) AND QOL LEIDEN-PADUA (LEIPAD) QUESTIONNAIRE. A TOTAL OF 65 ELDERLY MEN AND WOMEN WHO SIGNED AN INFORMED CONSENT AND COMPLETED QUESTIONNAIRES WERE INCLUDED IN THE STUDY. SLEEP QUALITY SCORE PSQI AND QOL (LEIPAD QUESTIONNAIRE) SCORE OF THE STUDY GROUP WERE EVALUATED AND COMPARED WITH THE CONTROL GROUP USING MANN-WHITNEY U TEST. RESULTS: TOTAL PSQI SCORE IN YOGA GROUP WAS LOWER THAN THAT OF THE CONTROL GROUP. ALSO VARIOUS QOL SCORES OF THE YOGA GROUPS WERE HIGHER THAN THE CONTROL GROUP. CONCLUSION: ADDITION OF REGULAR YOGA EXERCISES IN THE DAILY ROUTINE OF ELDERLY PEOPLE CAN HELP TO ACHIEVE GOOD SLEEP QUALITY AS WELL AS IMPROVE THE QOL. 2013 11 594 40 DEVELOPMENT AND FEASIBILITY OF A GROUP-BASED THERAPEUTIC YOGA PROGRAM FOR WOMEN WITH CHRONIC PELVIC PAIN. OBJECTIVE: TO DEVELOP A GROUP-BASED THERAPEUTIC YOGA PROGRAM FOR WOMEN WITH CHRONIC PELVIC PAIN (CPP) AND EXPLORE THE EFFECTS OF THIS PROGRAM ON PAIN SEVERITY, SEXUAL FUNCTION, AND WELL-BEING. METHODS: A YOGA THERAPY PROGRAM FOR CPP WAS DEVELOPED BY A MULTIDISCIPLINARY PANEL OF CLINICIANS, RESEARCHERS, AND YOGA CONSULTANTS. WOMEN REPORTING MODERATE TO SEVERE PELVIC PAIN FOR AT LEAST SIX MONTHS WERE RECRUITED INTO A SINGLE-ARM TRIAL. PARTICIPANTS ATTENDED TWICE WEEKLY GROUP CLASSES FOCUSING ON IYENGAR-BASED YOGA TECHNIQUES AND WERE INSTRUCTED TO PRACTICE YOGA AT HOME AN HOUR A WEEK FOR SIX WEEKS. PARTICIPANTS SELF-RATED THE SEVERITY OF THEIR PELVIC PAIN USING DAILY LOGS. THE IMPACT OF PARTICIPANTS' PAIN ON EVERYDAY ACTIVITIES, EMOTIONAL WELL-BEING, AND SEXUAL FUNCTION WAS ASSESSED USING AN IMPACT OF PELVIC PAIN (IPP) QUESTIONNAIRE. SEXUAL FUNCTION WAS FURTHER ASSESSED USING THE SEXUAL HEALTH OUTCOMES IN WOMEN QUESTIONNAIRE (SHOW-Q). RESULTS: AMONG THE 16 PARTICIPANTS (AGE RANGE = 31-64 YEARS), AVERAGE RATINGS OF THE SEVERITY OF PAIN "AT ITS WORST," "AT ITS BEST," AND "ON AVERAGE" DECREASED BY 29%, 32%, AND 34%, RESPECTIVELY, FROM START TO SIX WEEKS (P < 0.05 FOR ALL). WOMEN DEMONSTRATED IMPROVEMENTS IN SCORES ON IPP SUBSCALES FOR DAILY ACTIVITIES (1.8 +/- 0.7 TO 0.9 +/- 0.7, P < 0.001), EMOTIONAL WELL-BEING (1.7 +/- 0.9 TO 0.9 +/- 0.7, P = 0.005), AND SEXUAL FUNCTION (1.9 +/- 1.1 TO 1.0 +/- 0.9, P = 0.04). SCORES ON THE SHOW-Q "PELVIC PROBLEM INTERFERENCE" SCALE ALSO IMPROVED OVER SIX WEEKS (53 +/- 23 TO 27 +/- 23, P = 0.002). CONCLUSIONS: FINDINGS PROVIDE PRELIMINARY EVIDENCE OF THE FEASIBILITY OF TEACHING WOMEN WITH CPP TO PRACTICE YOGA TO SELF-MANAGE PAIN AND IMPROVE QUALITY OF LIFE AND SEXUAL FUNCTION. 2017 12 819 33 EFFECT OF YOGA ON DEPRESSION IN HYPOTHYROIDISM: A PILOT STUDY. BACKGROUND: THE PREVALENCE OF HYPOTHYROIDISM AMONG INDIAN WOMEN IS 15.8%. DEPRESSION IS FREQUENTLY REPORTED IN HYPOTHYROIDISM. YOGA IS AN EFFECTIVE INTERVENTION FOR DEPRESSION. HOWEVER, THE INFLUENCE OF YOGA ON DEPRESSION IN PATIENTS WITH HYPOTHYROIDISM HAS NOT BEEN STUDIED. AIM: THE PRESENT STUDY INVESTIGATED THE EFFECT OF A 3-MONTH INTEGRATED YOGA INTERVENTION (3-IY) ON DEPRESSION, LIPID INDICES, AND SERUM THYROID-STIMULATING HORMONE (STSH) LEVELS AMONG FEMALE PATIENTS HAVING HYPOTHYROIDISM, AND MILD-TO-MODERATE DEPRESSION. METHOD: THE PRESENT SINGLE-ARM PRE-POST DESIGN STUDY WAS CONDUCTED IN THIRTY-EIGHT WOMEN (AVERAGE AGE 34.2 +/- 4.7 YEARS). PARTICIPANTS RECEIVED A 3-IY COMPRISING ASANAS, PRANAYAMA, AND RELAXATION TECHNIQUES FOR 60 MIN DAILY (5 DAYS A WEEK). DEPRESSION, STSH, LIPID PROFILE INDICES, BODY MASS INDEX (BMI), FATIGUE, ANXIETY, AND STRESS WERE ASSESSED AT BASELINE AND AFTER 12 WEEKS. THYROID MEDICATION WAS KEPT CONSTANT DURING THE STUDY PERIOD. DATA WERE ANALYSED USING R STUDIO SOFTWARE. RESULT: A SIGNIFICANT (P < 0.05) REDUCTION IN DEPRESSION (58%), STSH (37%), BMI (6%), FATIGUE (64%), ANXIETY (57%), LIPID PROFILE INDICES (HLD INCREASED SIGNIFICANTY), AND STRESS (55%) LEVELS WAS OBSERVED AFTER 3 MONTHS, COMPARED WITH THE CORRESPONDING BASELINE LEVELS. CONCLUSION: THE 3-IY IS USEFUL FOR REDUCING DEPRESSION, DYSLIPIDEMIA, AND STSH IN WOMEN WITH HYPOTHYROIDISM AND DEPRESSION. FURTHER STUDIES WITH A LARGER SAMPLE SIZE AND A ROBUST RESEARCH DESIGN USING OBJECTIVE VARIABLES MUST BE CONDUCTED TO STRENGTHEN THE STUDY FINDINGS. 2021 13 748 29 EFFECT OF SAHAJA YOGA MEDITATION ON QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE CONTROL. OBJECTIVE: THE PRESENT STUDY INVESTIGATES THE EFFECT OF SAHAJA YOGA MEDITATION ON QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE CONTROL. DESIGN: THE PROSPECTIVE OBSERVATIONAL COHORT STUDY ENROLLED TWO STUDY GROUPS: THOSE RECEIVING TREATMENT FROM THE INTERNATIONAL SAHAJA YOGA RESEARCH AND HEALTH CENTER (MEDITATION GROUP) AND THOSE RECEIVING TREATMENT FROM THE MAHATMA GANDHI MISSION HOSPITAL (CONTROL GROUP). RESEARCHERS MEASURED QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE BEFORE AND AFTER TREATMENT. RESULTS: SIXTY-SEVEN (67) PARTICIPANTS IN THE MEDITATION GROUP AND 62 PARTICIPANTS IN THE CONTROL GROUP COMPLETED THE STUDY. THE TWO GROUPS WERE COMPARABLE IN DEMOGRAPHIC AND CLINICAL CHARACTERISTICS. AT BASELINE, THE MEDITATION GROUP HAD HIGHER QUALITY OF LIFE (P<0.001) THAN CONTROLS BUT SIMILAR ANXIETY LEVEL (P=0.74) TO CONTROLS. WITHIN-GROUP PRE- VERSUS POST-TREATMENT COMPARISONS SHOWED SIGNIFICANT IMPROVEMENT IN QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE IN THE MEDITATION GROUP (P<0.001), WHILE IN CONTROLS, QUALITY OF LIFE DETERIORATED AND THERE WAS NO IMPROVEMENT IN BLOOD PRESSURE. THE IMPROVEMENT IN QUALITY OF LIFE, ANXIETY REDUCTION, AND BLOOD PRESSURE CONTROL WAS GREATER IN THE MEDITATION GROUP. THE BENEFICIAL EFFECT OF MEDITATION REMAINED SIGNIFICANT AFTER ADJUSTING FOR CONFOUNDERS. CONCLUSIONS: MEDITATION TREATMENT WAS ASSOCIATED WITH SIGNIFICANT IMPROVEMENTS IN QUALITY OF LIFE, ANXIETY REDUCTION, AND BLOOD PRESSURE CONTROL. 2012 14 2260 36 THE PRACTICE OF HATHA YOGA FOR THE TREATMENT OF PAIN ASSOCIATED WITH ENDOMETRIOSIS. OBJECTIVES: THE AIM OF THIS STUDY WAS TO COMPARE CHRONIC PELVIC PAIN, MENSTRUAL PATTERNS, AND QUALITY OF LIFE (QOL) IN TWO GROUPS OF WOMEN WITH ENDOMETRIOSIS: THOSE WHO DID AND THOSE WHO DID NOT PARTICIPATE IN A SPECIFIC 8-WEEK YOGA INTERVENTION. METHOD: THIS WAS A RANDOMIZED CONTROLLED TRIAL. IT WAS CONDUCTED AT THE UNIVERSITY OF CAMPINAS MEDICAL SCHOOL, CAMPINAS, SP, BRAZIL. FORTY WOMEN WERE RANDOMLY DIVIDED INTO TWO GROUPS: AN INTERVENTION GROUP OF WOMEN WHO PRACTICED YOGA (N = 28), AND A CONTROL GROUP OF WOMEN WHO DID NOT PRACTICE YOGA (N = 12). PARTICIPANTS ATTENDED 90-MIN SCHEDULED YOGA SESSIONS TWICE A WEEK FOR 8 WEEKS. ADDITIONALLY, AN ENDOMETRIOSIS HEALTH PROFILE (EHP)-30 QUESTIONNAIRE WAS APPLIED TO EVALUATE WOMEN'S QOL AT ADMISSION AND 2 MONTHS LATER UPON COMPLETION OF THE YOGA PROGRAM. MENSTRUAL AND DAILY PAIN PATTERNS WERE EVALUATED THROUGH A DAILY CALENDAR (VISUAL ANALOG SCALE). RESULTS: THE DEGREE OF DAILY PAIN WAS SIGNIFICANTLY LOWER AMONG THE WOMEN WHO PRACTICED YOGA COMPARED WITH THE NON-YOGA GROUP (P = 0.0007). THERE WAS AN IMPROVEMENT OF QOL IN BOTH GROUPS BETWEEN BASELINE AND THE END OF THE STUDY EVALUATION. IN RELATION TO EHP-30 DOMAINS, PAIN (P = 0.0046), IMPOTENCE (P = 0.0006), WELL-BEING (P = 0.0009), AND IMAGE (P = 0.0087) FROM THE CENTRAL QUESTIONNAIRE, AND WORK (P = 0.0027) AND TREATMENT (P = 0.0245) FROM THE MODULAR QUESTIONNAIRE WERE SIGNIFICANTLY DIFFERENT BETWEEN THE STUDY GROUPS OVER TIME. THERE WAS NO SIGNIFICANT DIFFERENCE BETWEEN THE TWO GROUPS REGARDING THE DIARY OF MENSTRUAL PATTERNS (P = 0.96). CONCLUSIONS: YOGA PRACTICE WAS ASSOCIATED WITH A REDUCTION IN LEVELS OF CHRONIC PELVIC PAIN AND AN IMPROVEMENT IN QOL IN WOMEN WITH ENDOMETRIOSIS. 2017 15 2187 41 THE EFFECTS OF YOGA ON STUDENT MENTAL HEALTH: A RANDOMISED CONTROLLED TRIAL. BACKGROUND: UNIVERSITIES AROUND THE WORLD ARE FACING AN EPIDEMIC OF MENTAL DISTRESS AMONG THEIR STUDENTS. THE PROBLEM IS TRULY A PUBLIC HEALTH ISSUE, AFFECTING MANY AND WITH SERIOUS CONSEQUENCES. THE GLOBAL BURDEN OF DISEASE-AGENDA CALLS FOR EFFECTIVE INTERVENTIONS WITH LASTING EFFECTS THAT HAVE THE POTENTIAL TO IMPROVE THE MENTAL HEALTH OF YOUNG ADULTS. IN THIS STUDY WE AIMED TO DETERMINE WHETHER YOGA, A POPULAR AND WIDELY AVAILABLE MIND-BODY PRACTICE, CAN IMPROVE STUDENT MENTAL HEALTH. METHODS: WE PERFORMED A RANDOMISED CONTROLLED TRIAL WITH 202 HEALTHY UNIVERSITY STUDENTS IN THE OSLO AREA. THE PARTICIPANTS WERE ASSIGNED TO A YOGA GROUP OR WAITLIST CONTROL GROUP IN A 1:1 RATIO BY A SIMPLE ONLINE RANDOMISATION PROGRAM. THE INTERVENTION GROUP WAS OFFERED 24 YOGA SESSIONS OVER 12 WEEKS. MEASUREMENTS WERE TAKEN AT WEEK 0 (BASELINE), WEEK 12 (POST-INTERVENTION), AND WEEK 24 (FOLLOW-UP). THE PRIMARY OUTCOME WAS PSYCHOLOGICAL DISTRESS ASSESSED BY THE HSCL-25 QUESTIONNAIRE. ANALYSIS WAS PERFORMED BASED ON THE INTENTION TO TREAT-PRINCIPLE. RESULTS: BETWEEN 24 JANUARY 2017, AND 27 AUGUST 2017, WE RANDOMLY ASSIGNED 202 STUDENTS TO A YOGA INTERVENTION GROUP (N = 100), OR WAITLIST CONTROL GROUP (N = 102). COMPARED WITH THE CONTROL GROUP, THE YOGA PARTICIPANTS DEMONSTRATED A SIGNIFICANT REDUCTION IN DISTRESS SYMPTOMS BOTH AT POST-INTERVENTION (ADJUSTED DIFFERENCE IN THE MEAN CHANGE -0.15, 95% CI -0.26 TO -0.03, P = 0.0110) AND FOLLOW-UP (ADJUSTED DIFFERENCE IN THE MEAN CHANGE -0.18, 95% CI -0.29 TO -0.06, P = 0.0025). SLEEP QUALITY ALSO IMPROVED AT POST-INTERVENTION AND FOLLOW-UP. NO ADVERSE EVENTS WERE REPORTED. CONCLUSIONS: OUR FINDINGS SUGGEST THAT YOGA HAS A MODERATELY LARGE AND LASTING EFFECT, AT LEAST FOR SOME MONTHS, REDUCING SYMPTOMS OF DISTRESS AND IMPROVING SLEEP QUALITY AMONG STUDENTS. FURTHER RESEARCH SHOULD SEEK WAYS TO ENHANCE THE EFFECT, ASSESS AN EVEN LONGER FOLLOW-UP PERIOD, INCLUDE ACTIVE CONTROL GROUPS, AND CONSIDER PERFORMING SIMILAR STUDIES IN OTHER CULTURAL SETTINGS.TRIAL REGISTRATION: CLINICALTRIALS.GOV IDENTIFIER: NCT04258540. 2020 16 2461 33 YOGA AS A NOVEL ADJUVANT THERAPY FOR PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES. CONTEXT: RECENT STUDIES HAVE DEMONSTRATED THAT PHYSICAL ACTIVITY IS WELL TOLERATED BY PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) AND CAN HAVE ADDITIONAL BENEFITS AS AN ADJUVANT THERAPY TO PHARMACOLOGIC AGENTS, ESPECIALLY IF STARTED EARLY. TO DATE, NO STUDIES HAVE EXAMINED THE EFFECTS OF YOGA ON PATIENTS WITH IIMS. AIMS: THE AIM OF THIS STUDY WAS TO EVALUATE THE EFFECTS OF YOGA ON SELF-REPORTED DIFFICULTY IN PERFORMING ACTIVITIES OF DAILY LIVING (ADL) AND MUSCLE STRENGTH IN PATIENTS WITH MILD-TO-MODERATE IIMS. SUBJECTS AND METHODS: A LONGITUDINAL COHORT STUDY IN WHICH PARTICIPANTS WERE ASSESSED USING THE MYOSITIS ACTIVITIES PROFILE (MAP) AND MANUAL MUSCLE TESTING (MMT) BEFORE AND AFTER THE COMPLETION OF AN 8-WEEK INSTRUCTOR-GUIDED YOGA COURSE WAS PERFORMED. STATISTICAL ANALYSIS USED: WILCOXON SIGNED-RANKED TEST WAS PERFORMED FOR STATISTICAL ANALYSIS. RESULTS: THE AVERAGE POSTTREATMENT MAP SCORES OF SIX PARTICIPANTS DEMONSTRATED AN INCREASE OF 2.51 POINTS, WHILE THE AVERAGE MMT SCORE OF FOUR PARTICIPANTS DEMONSTRATED AN INCREASE OF 11 POINTS. CONCLUSIONS: THIS STUDY IS THE FIRST STUDY TO DATE TO EXAMINE THE EFFECT OF YOGA AS AN ADJUVANT COMPLEMENTARY THERAPY FOR PATIENTS WITH IIM. CONTINUED RESEARCH SHOULD BE DONE ON THE EFFECT OF YOGA AS AN ADJUVANT THERAPY, FOR IN ADDITION TO INCREASE IN MUSCLE STRENGTH AND ABILITY TO PERFORM ADL, YOGA MAY OFFER POTENTIAL IMPROVEMENTS IN MOOD, MENTAL HEALTH, AND SLEEP. 2021 17 290 36 ADJUNCTIVE YOGA V. HEALTH EDUCATION FOR PERSISTENT MAJOR DEPRESSION: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: THE OBJECTIVE OF THIS STUDY WAS TO DETERMINE WHETHER HATHA YOGA IS AN EFFICACIOUS ADJUNCTIVE INTERVENTION FOR INDIVIDUALS WITH CONTINUED DEPRESSIVE SYMPTOMS DESPITE ANTIDEPRESSANT TREATMENT. METHOD: WE CONDUCTED A RANDOMIZED CONTROLLED TRIAL OF WEEKLY YOGA CLASSES (N = 63) V. HEALTH EDUCATION CLASSES (HEALTHY LIVING WORKSHOP; HLW; N = 59) IN INDIVIDUALS WITH ELEVATED DEPRESSION SYMPTOMS AND ANTIDEPRESSANT MEDICATION USE. HLW SERVED AS AN ATTENTION-CONTROL GROUP. THE INTERVENTION PERIOD WAS 10 WEEKS, WITH FOLLOW-UP ASSESSMENTS 3 AND 6 MONTHS AFTERWARDS. THE PRIMARY OUTCOME WAS DEPRESSION SYMPTOM SEVERITY ASSESSED BY BLIND RATER AT 10 WEEKS. SECONDARY OUTCOMES INCLUDED DEPRESSION SYMPTOMS OVER THE ENTIRE INTERVENTION AND FOLLOW-UP PERIODS, SOCIAL AND ROLE FUNCTIONING, GENERAL HEALTH PERCEPTIONS, PAIN, AND PHYSICAL FUNCTIONING. RESULTS: AT 10 WEEKS, WE DID NOT FIND A STATISTICALLY SIGNIFICANT DIFFERENCE BETWEEN GROUPS IN DEPRESSION SYMPTOMS (B = -0.82, S.E. = 0.88, P = 0.36). HOWEVER, OVER THE ENTIRE INTERVENTION AND FOLLOW-UP PERIOD, WHEN CONTROLLING FOR BASELINE, YOGA PARTICIPANTS SHOWED LOWER LEVELS OF DEPRESSION THAN HLW PARTICIPANTS (B = -1.38, S.E. = 0.57, P = 0.02). AT 6-MONTH FOLLOW-UP, 51% OF YOGA PARTICIPANTS DEMONSTRATED A RESPONSE (50% REDUCTION IN DEPRESSION SYMPTOMS) COMPARED WITH 31% OF HLW PARTICIPANTS (ODDS RATIO = 2.31; P = 0.04). YOGA PARTICIPANTS SHOWED SIGNIFICANTLY BETTER SOCIAL AND ROLE FUNCTIONING AND GENERAL HEALTH PERCEPTIONS OVER TIME. CONCLUSIONS: ALTHOUGH WE DID NOT SEE A DIFFERENCE IN DEPRESSION SYMPTOMS AT THE END OF THE INTERVENTION PERIOD, YOGA PARTICIPANTS SHOWED FEWER DEPRESSION SYMPTOMS OVER THE ENTIRE FOLLOW-UP PERIOD. BENEFITS OF YOGA MAY ACCUMULATE OVER TIME. 2017 18 2173 25 THE EFFECTS OF YOGA ON DYSPNEA, SLEEP AND FATIGUE IN CHRONIC RESPIRATORY DISEASES. PURPOSE: THIS STUDY WAS CARRIED OUT TO FIND OUT THE EFFECTS OF YOGA APPLIED TO CHRONIC RESPIRATORY DISEASE PATIENTS ON DYSPNEA, SLEEP QUALITY AND FATIGUE. MATERIAL AND METHOD: THE STUDY WAS CONDUCTED BETWEEN MAY AND AUGUST 2020 AS A RANDOMIZED CONTROLLED STUDY. 'PERSONAL INFORMATION FORM', 'RESPIRATORY FUNCTIONS MONITORING FORM', 'COPD AND ASTHMA FATIGUE SCALE (CAFS), "ASTHMA AND COPD SLEEP IMPACT SCALE (CASIS)" AND MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE (MMRC) WERE USED IN DATA COLLECTION. RESULTS: WHEN THE POST-TEST MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL AND CONTROL GROUP WERE COMPARED, IT WAS FOUND THAT CAFS, CASIS AND MMRC MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL GROUP DECREASED POSITIVELY COMPARED TO THE PATIENTS IN THE CONTROL GROUP AND THE DIFFERENCE BETWEEN WAS FOUND TO BE STATISTICALLY SIGNIFICANT (P < 0.05). CONCLUSION: YOGA HAS BEEN FOUND TO REDUCE THE SEVERITY OF DYSPNEA AND FATIGUE AND IMPROVE SLEEP QUALITY IN CHRONIC RESPIRATORY DISEASES. 2021 19 2319 33 TREATING THE CLIMACTERIC SYMPTOMS IN INDIAN WOMEN WITH AN INTEGRATED APPROACH TO YOGA THERAPY: A RANDOMIZED CONTROL STUDY. OBJECTIVE: TO STUDY THE EFFECT OF YOGA ON THE CLIMACTERIC SYMPTOMS, PERCEIVED STRESS, AND PERSONALITY IN PERIMENOPAUSAL WOMEN. DESIGN: ONE HUNDRED TWENTY PARTICIPANTS (AGES 40-55 Y) WERE RANDOMLY DIVIDED INTO TWO STUDY ARMS, IE, YOGA AND CONTROL. THE YOGA GROUP PRACTICED AN INTEGRATED APPROACH TO YOGA THERAPY COMPRISING SURYA NAMASKARA (SUN SALUTATION) WITH 12 POSTURES, PRANAYAMA (BREATHING PRACTICES), AND AVARTAN DHYAN (CYCLIC MEDITATION), WHEREAS THE CONTROL GROUP PRACTICED A SET OF SIMPLE PHYSICAL EXERCISES UNDER SUPERVISION OF TRAINED TEACHERS FOR 8 WEEKS (1 H DAILY, 5 DAYS PER WEEK). THE ASSESSMENTS WERE MADE BY GREENE CLIMACTERIC SCALE, PERCEIVED STRESS SCALE, AND EYSENCK'S PERSONALITY INVENTORY BEFORE AND AFTER THE INTERVENTION. RESULTS: OF THE THREE FACTORS OF THE GREENE CLIMACTERIC SCALE, THE MANN-WHITNEY TEST SHOWED A SIGNIFICANT DIFFERENCE BETWEEN GROUPS (P < 0.05) IN THE VASOMOTOR SYMPTOMS, A MARGINALLY SIGNIFICANT DIFFERENCE (P = 0.06) IN PSYCHOLOGICAL FACTORS BUT NOT IN THE SOMATIC COMPONENT. EFFECT SIZES WERE HIGHER IN THE YOGA GROUP FOR ALL FACTORS. THERE WAS A SIGNIFICANTLY GREATER DEGREE OF DECREASE IN PERCEIVED STRESS SCALE SCORES (P < 0.001, INDEPENDENT SAMPLES T TEST) IN THE YOGA GROUP COMPARED WITH CONTROLS (BETWEEN-GROUP ANALYSIS) WITH A HIGHER EFFECT SIZE IN THE YOGA GROUP (1.10) THAN THE CONTROL (0.27). ON THE EYSENCK'S PERSONALITY INVENTORY, THE DECREASE IN NEUROTICISM WAS GREATER (P < 0.05) IN THE YOGA GROUP (EFFECT SIZE = 0.43) THAN THE CONTROL GROUP (EFFECT SIZE = 0.21) WITH NO CHANGE IN EXTROVERSION IN EITHER THE YOGA OR CONTROL GROUP. CONCLUSIONS: EIGHT WEEKS OF AN INTEGRATED APPROACH TO YOGA THERAPY DECREASES CLIMACTERIC SYMPTOMS, PERCEIVED STRESS, AND NEUROTICISM IN PERIMENOPAUSAL WOMEN BETTER THAN PHYSICAL EXERCISE. 2008 20 1125 39 EFFICACY OF SHORT-TERM YOGA THERAPY PROGRAM ON QUALITY OF LIFE IN PATIENTS WITH PSYCHOSOMATIC AILMENTS. OBJECTIVE: THE AIM WAS TO STUDY THE EFFECT OF SHORT-TERM YOGA THERAPY PROGRAM ON QUALITY OF LIFE IN PATIENTS SUFFERING FROM PSYCHOSOMATIC AILMENTS. METHODS: SAMPLE SIZE AND STUDY PERIOD: ALL THE SUBJECTS COMING TO SVYASA AROGYADHAMA IN MONTH OF JULY 2011 FOR YOGA THERAPY FOR VARIOUS PSYCHOSOMATIC AILMENTS AND WERE FREE OF ANY PRIMARY PSYCHIATRIC ILLNESS AND VOLUNTEERING TO PARTICIPATE WERE ENROLLED IN THE STUDY AFTER TAKING INFORMED CONSENT. THEIR PHYSICAL CONDITION WAS HEALTHY ENOUGH TO PRACTICE YOGA AS JUDGED CLINICALLY. ALL SUBJECTS (N = 94) WHO WERE ENROLLED IN THE STUDY UNDERWENT INTEGRATED APPROACH TO YOGA THERAPY, WHICH INCLUDED ASANAS, PRANAYAMAS, MEDITATION, KRIYAS AND LECTURES ON PRACTICE OF YOGA AND DERIVED SPECIAL TECHNIQUES IN THEIR RESPECTIVE SECTIONS. THE QUALITY OF LIFE WAS ASSESSED BY SF-12 QUESTIONNAIRE AND THEREBY CALCULATING PHYSICAL AND MENTAL COMPOSITE SCORES (PCS AND MCS) BEFORE AND AFTER 1 WEEK OF YOGA THERAPY. DATA THUS OBTAINED WAS ANALYZED USING PAIRED T-TEST. RESULTS: A SIGNIFICANT IMPROVEMENT (P < 0.001) WAS SEEN IN THE STUDY GROUP IN BOTH PCS (FROM MEAN +/- SD OF 37.50 +/- 9.58 TO 43.7 +/- 8.73) AND MCS (FROM 45.87 +/- 9.57 TO 53.35 +/- 7.9.) WITH MINOR VARIATIONS IN PATIENTS OF VARIOUS DEPARTMENTS. CONCLUSION: A SHORT-TERM YOGA THERAPY PROGRAM LEADS TO A REMARKABLE IMPROVEMENT IN THE QUALITY OF LIFE OF THE SUBJECTS AND CAN CONTRIBUTE FAVORABLY IN THE MANAGEMENT OF PSYCHOSOMATIC DISORDERS. 2015